Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Stock Performance

Milestone Scientific stock opened at $1.02 on Friday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The stock has a market cap of $79.06 million, a P/E ratio of -14.50 and a beta of 1.10. The firm’s fifty day moving average price is $0.83 and its 200-day moving average price is $0.87.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 24.75% of the stock is currently owned by company insiders.

Institutional Trading of Milestone Scientific

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the third quarter valued at about $48,000. World Investment Advisors LLC bought a new stake in shares of Milestone Scientific in the 3rd quarter valued at about $91,000. Finally, Geode Capital Management LLC grew its position in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.